Werewolf Therapeutics Inc (HOWL)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Daniel J. Hicklin
Employees:
40
1030 MASSACHUSETTS AVENUE, SUITE 210, CAMBRIDGE, MA 02138
617-952-0555

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies.

Data derived from most recent annual or quarterly report
Market Cap 98.06 Million Shares Outstanding35.658 Million Avg 30-day Volume 387.623 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.53
Price to Revenue4.3734 Debt to Equity0.33 EBITDA-42.065 Million
Price to Book Value0.9144 Operating Margin-177.4659 Enterprise Value10.142 Million
Current Ratio9.823 EPS Growth-1.017 Quick Ratio9.621
1 Yr BETA 1.3475 52-week High/Low 4.57 / 1.39 Profit Margin-165.1464
Operating Cash Flow Growth-19.8683 Free Cash Flow to Firm (FCFF) TTM -66.966 Million Free Cash Flow to Equity (FCFE) TTM-33.628 Million
Altman Z-Score-1.2631

View recent insider trading info

Werewolf Therapeutics Inc YCharts
Yahoo! Finance finviz

Funds Holding HOWL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HOWL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EVNIN LUKE

  • Director
 0 2023-06-21 1

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
 0 2023-06-21 2

SHERMAN MICHAEL A.

  • Director
 0 2023-06-21 1

MORRISON BRIGGS

  • Director
 0 2023-06-21 1

DIROCCO DEREK

  • Director
 0 2023-06-21 1

LAZARUS ALON

  • Director
 0 2023-06-21 1

CHATTERJEE MEETA

  • Director
 0 2023-06-21 1

HICKLIN DANIEL J SEE REMARKS

  • Officer
  • Director
 295,500 2023-01-03 1

TROST TIMOTHY W. CHIEF FINANCIAL OFFICER

  • Officer
 102,800 2023-01-03 1

LEONARD REID CHIEF OPERATING OFFICER

  • Officer
 93,600 2023-01-03 1

ISAACS RANDI CHIEF MEDICAL OFFICER

  • Officer
 103,300 2023-01-03 1

SEIDEL-DUGAN CYNTHIA CHIEF SCIENTIFIC OFFICER

  • Officer
 115,900 2023-01-03 1

LUBMAN ELLEN CHIEF BUSINESS OFFICER

  • Officer
 86,200 2023-01-03 1

KARUNATILAKE CHULANI CHIEF TECHNOLOGY OFFICER

  • Officer
 103,600 2023-01-03 1

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PARTNERS, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
 No longer subject to file 2021-05-04 0

GADICKE ANSBERT

MPM ONCOLOGY INNOVATIONS FUND LP

UBS ONCOLOGY IMPACT FUND L.P.

ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.

MPM ONCOLOGY IMPACT MANAGEMENT LP

MPM ONCOLOGY INNOVATIONS FUND GP LLC

MPM ONCOLOGY IMPACT MANAGEMENT GP LLC

  • 10% Owner
 6,672,183 2021-05-04 0

HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.

  • 10% Owner
 No longer subject to file 2021-05-04 0

ARKIN BIO VENTURES 2 L.P.

ARKIN BIO VENTURES GPGP LTD.

ARKIN MOSHE

  • 10% Owner
 No longer subject to file 2021-05-04 0

MPM BIOVENTURES 2014, L.P.

MPM BIOVENTURES 2014 (B), L.P.

MPM BIOVENTURES 2014 LLC

MPM BIOVENTURES 2014 GP LLC

FOLEY TODD

MPM ASSET MANAGEMENT INVESTORS BV2014 LLC

  • 10% Owner
 3,187,998 2021-05-04 0

SPHERA GLOBAL HEALTHCARE MANAGEMENT LP

SPHERA GLOBAL HEALTHCARE GP LTD.

SPHERA FUNDS MANAGEMENT LTD.

  • 10% Owner
 No longer subject to file 2021-05-04 0

LONGWOOD FUND III GP, LLC

LONGWOOD FUND III, L.P.

  • 10% Owner
 No longer subject to file 2021-05-04 0

UPMC

  • 10% Owner
 No longer subject to file 2021-05-04 0

TAIHO VENTURES LLC

  • 10% Owner
 No longer subject to file 2021-05-04 0

ASANUMA SAKAE

  • Director
  • 10% Owner
 2,068,909 2021-04-29 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 18:45:04 UTC -13.4428 18.7628 350000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 18:15:03 UTC -13.4428 18.7628 350000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 17:45:04 UTC -13.4428 18.7628 350000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 17:15:04 UTC -13.4428 18.7628 350000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 16:45:04 UTC -13.4428 18.7628 300000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 16:15:04 UTC -13.4428 18.7628 300000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 15:45:04 UTC -13.4428 18.7628 300000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 15:15:05 UTC -13.4428 18.7628 300000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 14:45:03 UTC -13.4428 18.7628 300000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 14:15:04 UTC -13.4428 18.7628 300000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 13:45:04 UTC -12.4487 17.7687 300000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 13:15:04 UTC -12.4487 17.7687 300000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-05 12:45:05 UTC -12.4487 17.7687 95000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-04 22:15:04 UTC -12.5708 17.8908 100000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-04 21:45:03 UTC -12.5708 17.8908 100000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-04 21:15:03 UTC -12.5708 17.8908 100000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-04 20:45:04 UTC -12.5708 17.8908 100000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-04 20:15:05 UTC -12.7542 18.0742 100000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-04 19:45:03 UTC -12.7542 18.0742 100000
WEREWOLF THERAPEUTICS INC HOWL 2023-12-04 19:15:04 UTC -12.7542 18.0742 95000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments